Skip to main content

Table 1 Criteria for study inclusion/exclusion

From: The impact of ginsenosides on cognitive deficits in experimental animal studies of Alzheimer’s disease: a systematic review

Inclusion criteria

Exclusion criteria

(1) Ginsenoside were administered.

(1) Ginsenoside were not administered.

(2) Experimental AD was induced in rodents (i.e., rats or mice).

(2) Other types of animals (e.g., sheep, cats, and dogs) were used.

(3) AD treatment group was treated with a pharmacological agent, and a control group was administered a placebo after injury.

(3) Treatment group was administered another neuroprotective agent in addition to ginsenoside.

(4) Cognitive function was measured by the MWM.

(4) Treatment group was administered another Chinese Traditional medicine in addition to ginsenoside.

(5) Article was published in English or Chinese language.

(5) Only biochemical or physiological outcomes of treatment efficacy were assessed.

 

(6) No control group was used. (8) Duplicate publications.